0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Breast Cancer Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-17N9030
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Breast Cancer Screening Market Outlook 2022
BUY CHAPTERS

Breast Cancer Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-17N9030
Report
August 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Breast Cancer Screening- Market Size

The global market for Breast Cancer Screening was estimated to be worth US$ 56.3 million in 2024 and is forecast to a readjusted size of US$ 98 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.

Breast Cancer Screening- Market

Breast Cancer Screening- Market

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Screening, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Breast Cancer Screening by region & country, by Type, and by Application.
The Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Screening.
Market Segmentation

Scope of Breast Cancer Screening- Market Report

Report Metric Details
Report Name Breast Cancer Screening- Market
Forecasted market size in 2031 US$ 98 million
CAGR 8.4%
Forecasted years 2025 - 2031
Segment by Type
  • Mammography Screening
  • Breast Magnetic Resonance Imaging (MRI) Screening
  • Breast Ultrasound Screening
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Breast Cancer Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Breast Cancer Screening- Market size in 2031?

Ans: The Breast Cancer Screening- Market size in 2031 will be US$ 98 million.

What is the market share of major companies in Breast Cancer Screening- Market?

Ans: Global top three manufacturers hold a share about 65%.

What is the Breast Cancer Screening- Market share by type?

Ans: In terms of product, Mammography Screening is the largest segment, with a share about 70%.

Who are the main players in the Breast Cancer Screening- Market report?

Ans: The main players in the Breast Cancer Screening- Market are Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl

What are the Application segmentation covered in the Breast Cancer Screening- Market report?

Ans: The Applications covered in the Breast Cancer Screening- Market report are Hospital, Clinic

What are the Type segmentation covered in the Breast Cancer Screening- Market report?

Ans: The Types covered in the Breast Cancer Screening- Market report are Mammography Screening, Breast Magnetic Resonance Imaging (MRI) Screening, Breast Ultrasound Screening

1 Market Overview
1.1 Breast Cancer Screening Product Introduction
1.2 Global Breast Cancer Screening Market Size Forecast
1.2.1 Global Breast Cancer Screening Sales Value (2020-2031)
1.2.2 Global Breast Cancer Screening Sales Volume (2020-2031)
1.2.3 Global Breast Cancer Screening Sales Price (2020-2031)
1.3 Breast Cancer Screening Market Trends & Drivers
1.3.1 Breast Cancer Screening Industry Trends
1.3.2 Breast Cancer Screening Market Drivers & Opportunity
1.3.3 Breast Cancer Screening Market Challenges
1.3.4 Breast Cancer Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Breast Cancer Screening Players Revenue Ranking (2024)
2.2 Global Breast Cancer Screening Revenue by Company (2020-2025)
2.3 Global Breast Cancer Screening Players Sales Volume Ranking (2024)
2.4 Global Breast Cancer Screening Sales Volume by Company Players (2020-2025)
2.5 Global Breast Cancer Screening Average Price by Company (2020-2025)
2.6 Key Manufacturers Breast Cancer Screening Manufacturing Base and Headquarters
2.7 Key Manufacturers Breast Cancer Screening Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Breast Cancer Screening
2.9 Breast Cancer Screening Market Competitive Analysis
2.9.1 Breast Cancer Screening Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Breast Cancer Screening Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mammography Screening
3.1.2 Breast Magnetic Resonance Imaging (MRI) Screening
3.1.3 Breast Ultrasound Screening
3.2 Global Breast Cancer Screening Sales Value by Type
3.2.1 Global Breast Cancer Screening Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Breast Cancer Screening Sales Value, by Type (2020-2031)
3.2.3 Global Breast Cancer Screening Sales Value, by Type (%) (2020-2031)
3.3 Global Breast Cancer Screening Sales Volume by Type
3.3.1 Global Breast Cancer Screening Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Breast Cancer Screening Sales Volume, by Type (2020-2031)
3.3.3 Global Breast Cancer Screening Sales Volume, by Type (%) (2020-2031)
3.4 Global Breast Cancer Screening Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Breast Cancer Screening Sales Value by Application
4.2.1 Global Breast Cancer Screening Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Breast Cancer Screening Sales Value, by Application (2020-2031)
4.2.3 Global Breast Cancer Screening Sales Value, by Application (%) (2020-2031)
4.3 Global Breast Cancer Screening Sales Volume by Application
4.3.1 Global Breast Cancer Screening Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Breast Cancer Screening Sales Volume, by Application (2020-2031)
4.3.3 Global Breast Cancer Screening Sales Volume, by Application (%) (2020-2031)
4.4 Global Breast Cancer Screening Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Breast Cancer Screening Sales Value by Region
5.1.1 Global Breast Cancer Screening Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Breast Cancer Screening Sales Value by Region (2020-2025)
5.1.3 Global Breast Cancer Screening Sales Value by Region (2026-2031)
5.1.4 Global Breast Cancer Screening Sales Value by Region (%), (2020-2031)
5.2 Global Breast Cancer Screening Sales Volume by Region
5.2.1 Global Breast Cancer Screening Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Breast Cancer Screening Sales Volume by Region (2020-2025)
5.2.3 Global Breast Cancer Screening Sales Volume by Region (2026-2031)
5.2.4 Global Breast Cancer Screening Sales Volume by Region (%), (2020-2031)
5.3 Global Breast Cancer Screening Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Breast Cancer Screening Sales Value, 2020-2031
5.4.2 North America Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Breast Cancer Screening Sales Value, 2020-2031
5.5.2 Europe Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Breast Cancer Screening Sales Value, 2020-2031
5.6.2 Asia Pacific Breast Cancer Screening Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Breast Cancer Screening Sales Value, 2020-2031
5.7.2 South America Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Breast Cancer Screening Sales Value, 2020-2031
5.8.2 Middle East & Africa Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Breast Cancer Screening Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Breast Cancer Screening Sales Value
6.2.1 Key Countries/Regions Breast Cancer Screening Sales Value, 2020-2031
6.2.2 Key Countries/Regions Breast Cancer Screening Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Breast Cancer Screening Sales Value, 2020-2031
6.3.2 United States Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Breast Cancer Screening Sales Value, 2020-2031
6.4.2 Europe Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Breast Cancer Screening Sales Value, 2020-2031
6.5.2 China Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.5.3 China Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Breast Cancer Screening Sales Value, 2020-2031
6.6.2 Japan Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Breast Cancer Screening Sales Value, 2020-2031
6.7.2 South Korea Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Breast Cancer Screening Sales Value, 2020-2031
6.8.2 Southeast Asia Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Breast Cancer Screening Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Breast Cancer Screening Sales Value, 2020-2031
6.9.2 India Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
6.9.3 India Breast Cancer Screening Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Hologic
7.1.1 Hologic Company Information
7.1.2 Hologic Introduction and Business Overview
7.1.3 Hologic Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Hologic Breast Cancer Screening Product Offerings
7.1.5 Hologic Recent Development
7.2 GE Healthcare
7.2.1 GE Healthcare Company Information
7.2.2 GE Healthcare Introduction and Business Overview
7.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 GE Healthcare Breast Cancer Screening Product Offerings
7.2.5 GE Healthcare Recent Development
7.3 Siemen Healthineers
7.3.1 Siemen Healthineers Company Information
7.3.2 Siemen Healthineers Introduction and Business Overview
7.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Siemen Healthineers Breast Cancer Screening Product Offerings
7.3.5 Siemen Healthineers Recent Development
7.4 Philips Healthcare
7.4.1 Philips Healthcare Company Information
7.4.2 Philips Healthcare Introduction and Business Overview
7.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Philips Healthcare Breast Cancer Screening Product Offerings
7.4.5 Philips Healthcare Recent Development
7.5 Canon Medical
7.5.1 Canon Medical Company Information
7.5.2 Canon Medical Introduction and Business Overview
7.5.3 Canon Medical Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Canon Medical Breast Cancer Screening Product Offerings
7.5.5 Canon Medical Recent Development
7.6 Fujifilm
7.6.1 Fujifilm Company Information
7.6.2 Fujifilm Introduction and Business Overview
7.6.3 Fujifilm Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Fujifilm Breast Cancer Screening Product Offerings
7.6.5 Fujifilm Recent Development
7.7 Metaltronica
7.7.1 Metaltronica Company Information
7.7.2 Metaltronica Introduction and Business Overview
7.7.3 Metaltronica Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Metaltronica Breast Cancer Screening Product Offerings
7.7.5 Metaltronica Recent Development
7.8 Sino Medical-Device
7.8.1 Sino Medical-Device Company Information
7.8.2 Sino Medical-Device Introduction and Business Overview
7.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sino Medical-Device Breast Cancer Screening Product Offerings
7.8.5 Sino Medical-Device Recent Development
7.9 IMS Srl
7.9.1 IMS Srl Company Information
7.9.2 IMS Srl Introduction and Business Overview
7.9.3 IMS Srl Breast Cancer Screening Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 IMS Srl Breast Cancer Screening Product Offerings
7.9.5 IMS Srl Recent Development
8 Industry Chain Analysis
8.1 Breast Cancer Screening Industrial Chain
8.2 Breast Cancer Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Breast Cancer Screening Sales Model
8.5.2 Sales Channel
8.5.3 Breast Cancer Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Breast Cancer Screening Market Trends
 Table 2. Breast Cancer Screening Market Drivers & Opportunity
 Table 3. Breast Cancer Screening Market Challenges
 Table 4. Breast Cancer Screening Market Restraints
 Table 5. Global Breast Cancer Screening Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Breast Cancer Screening Revenue Market Share by Company (2020-2025)
 Table 7. Global Breast Cancer Screening Sales Volume by Company (2020-2025) & (Units)
 Table 8. Global Breast Cancer Screening Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Breast Cancer Screening Price by Company (2020-2025) & (K USD/Unit)
 Table 10. Key Manufacturers Breast Cancer Screening Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Breast Cancer Screening Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Breast Cancer Screening
 Table 13. Global Breast Cancer Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Breast Cancer Screening Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Breast Cancer Screening Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Breast Cancer Screening Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Breast Cancer Screening Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Breast Cancer Screening Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Breast Cancer Screening Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
 Table 22. Global Breast Cancer Screening Sales Volume by Type (2020-2025) & (Units)
 Table 23. Global Breast Cancer Screening Sales Volume by Type (2026-2031) & (Units)
 Table 24. Global Breast Cancer Screening Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Breast Cancer Screening Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Breast Cancer Screening Price by Type (2020-2025) & (K USD/Unit)
 Table 27. Global Breast Cancer Screening Price by Type (2026-2031) & (K USD/Unit)
 Table 28. Global Breast Cancer Screening Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Breast Cancer Screening Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Breast Cancer Screening Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Breast Cancer Screening Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Breast Cancer Screening Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Breast Cancer Screening Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
 Table 34. Global Breast Cancer Screening Sales Volume by Application (2020-2025) & (Units)
 Table 35. Global Breast Cancer Screening Sales Volume by Application (2026-2031) & (Units)
 Table 36. Global Breast Cancer Screening Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Breast Cancer Screening Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Breast Cancer Screening Price by Application (2020-2025) & (K USD/Unit)
 Table 39. Global Breast Cancer Screening Price by Application (2026-2031) & (K USD/Unit)
 Table 40. Global Breast Cancer Screening Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Breast Cancer Screening Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Breast Cancer Screening Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Breast Cancer Screening Sales Value by Region (2020-2025) & (%)
 Table 44. Global Breast Cancer Screening Sales Value by Region (2026-2031) & (%)
 Table 45. Global Breast Cancer Screening Sales Volume by Region (Units): 2020 VS 2024 VS 2031
 Table 46. Global Breast Cancer Screening Sales Volume by Region (2020-2025) & (Units)
 Table 47. Global Breast Cancer Screening Sales Volume by Region (2026-2031) & (Units)
 Table 48. Global Breast Cancer Screening Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Breast Cancer Screening Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Breast Cancer Screening Average Price by Region (2020-2025) & (K USD/Unit)
 Table 51. Global Breast Cancer Screening Average Price by Region (2026-2031) & (K USD/Unit)
 Table 52. Key Countries/Regions Breast Cancer Screening Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Breast Cancer Screening Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Breast Cancer Screening Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Breast Cancer Screening Sales Volume, (2020-2025) & (Units)
 Table 56. Key Countries/Regions Breast Cancer Screening Sales Volume, (2026-2031) & (Units)
 Table 57. Hologic Company Information
 Table 58. Hologic Introduction and Business Overview
 Table 59. Hologic Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 60. Hologic Breast Cancer Screening Product Offerings
 Table 61. Hologic Recent Development
 Table 62. GE Healthcare Company Information
 Table 63. GE Healthcare Introduction and Business Overview
 Table 64. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 65. GE Healthcare Breast Cancer Screening Product Offerings
 Table 66. GE Healthcare Recent Development
 Table 67. Siemen Healthineers Company Information
 Table 68. Siemen Healthineers Introduction and Business Overview
 Table 69. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 70. Siemen Healthineers Breast Cancer Screening Product Offerings
 Table 71. Siemen Healthineers Recent Development
 Table 72. Philips Healthcare Company Information
 Table 73. Philips Healthcare Introduction and Business Overview
 Table 74. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 75. Philips Healthcare Breast Cancer Screening Product Offerings
 Table 76. Philips Healthcare Recent Development
 Table 77. Canon Medical Company Information
 Table 78. Canon Medical Introduction and Business Overview
 Table 79. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 80. Canon Medical Breast Cancer Screening Product Offerings
 Table 81. Canon Medical Recent Development
 Table 82. Fujifilm Company Information
 Table 83. Fujifilm Introduction and Business Overview
 Table 84. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 85. Fujifilm Breast Cancer Screening Product Offerings
 Table 86. Fujifilm Recent Development
 Table 87. Metaltronica Company Information
 Table 88. Metaltronica Introduction and Business Overview
 Table 89. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 90. Metaltronica Breast Cancer Screening Product Offerings
 Table 91. Metaltronica Recent Development
 Table 92. Sino Medical-Device Company Information
 Table 93. Sino Medical-Device Introduction and Business Overview
 Table 94. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 95. Sino Medical-Device Breast Cancer Screening Product Offerings
 Table 96. Sino Medical-Device Recent Development
 Table 97. IMS Srl Company Information
 Table 98. IMS Srl Introduction and Business Overview
 Table 99. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2020-2025)
 Table 100. IMS Srl Breast Cancer Screening Product Offerings
 Table 101. IMS Srl Recent Development
 Table 102. Key Raw Materials Lists
 Table 103. Raw Materials Key Suppliers Lists
 Table 104. Breast Cancer Screening Downstream Customers
 Table 105. Breast Cancer Screening Distributors List
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources


List of Figures
 Figure 1. Breast Cancer Screening Product Picture
 Figure 2. Global Breast Cancer Screening Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Breast Cancer Screening Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Breast Cancer Screening Sales Volume (2020-2031) & (Units)
 Figure 5. Global Breast Cancer Screening Sales Price (2020-2031) & (K USD/Unit)
 Figure 6. Breast Cancer Screening Report Years Considered
 Figure 7. Global Breast Cancer Screening Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Breast Cancer Screening Players Sales Volume Ranking (2024) & (Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Breast Cancer Screening Revenue in 2024
 Figure 10. Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Mammography Screening Picture
 Figure 12. Breast Magnetic Resonance Imaging (MRI) Screening Picture
 Figure 13. Breast Ultrasound Screening Picture
 Figure 14. Global Breast Cancer Screening Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Breast Cancer Screening Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Global Breast Cancer Screening Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
 Figure 17. Global Breast Cancer Screening Sales Volume Market Share by Type, 2024 & 2031
 Figure 18. Global Breast Cancer Screening Price by Type (2020-2031) & (K USD/Unit)
 Figure 19. Product Picture of Hospital
 Figure 20. Product Picture of Clinic
 Figure 21. Global Breast Cancer Screening Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Breast Cancer Screening Sales Value Market Share by Application, 2024 & 2031
 Figure 23. Global Breast Cancer Screening Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
 Figure 24. Global Breast Cancer Screening Sales Volume Market Share by Application, 2024 & 2031
 Figure 25. Global Breast Cancer Screening Price by Application (2020-2031) & (K USD/Unit)
 Figure 26. North America Breast Cancer Screening Sales Value (2020-2031) & (US$ Million)
 Figure 27. North America Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
 Figure 28. Europe Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 29. Europe Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
 Figure 30. Asia Pacific Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Breast Cancer Screening Sales Value by Region (%), 2024 VS 2031
 Figure 32. South America Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 33. South America Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
 Figure 34. Middle East & Africa Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 35. Middle East & Africa Breast Cancer Screening Sales Value by Country (%), 2024 VS 2031
 Figure 36. Key Countries/Regions Breast Cancer Screening Sales Value (%), (2020-2031)
 Figure 37. Key Countries/Regions Breast Cancer Screening Sales Volume (%), (2020-2031)
 Figure 38. United States Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 39. United States Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 40. United States Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 41. Europe Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 42. Europe Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 43. Europe Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 44. China Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 45. China Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 46. China Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 47. Japan Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 48. Japan Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 49. Japan Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 50. South Korea Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 51. South Korea Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 52. South Korea Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 53. Southeast Asia Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 54. Southeast Asia Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 55. Southeast Asia Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 56. India Breast Cancer Screening Sales Value, (2020-2031) & (US$ Million)
 Figure 57. India Breast Cancer Screening Sales Value by Type (%), 2024 VS 2031
 Figure 58. India Breast Cancer Screening Sales Value by Application (%), 2024 VS 2031
 Figure 59. Breast Cancer Screening Industrial Chain
 Figure 60. Breast Cancer Screening Manufacturing Cost Structure
 Figure 61. Channels of Distribution (Direct Sales, and Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India